Luminex® Corporation (NASDAQ: LMNX) develops, manufactures and markets proprietary biological testing technologies, with applications throughout the life-sciences industry.
AUSTIN, Texas, Dec. 11, 2018 /PRNewswire/ -- Luminex Corporation (Nasdaq:LMNX) (the "Company"), today announced that its board of directors declared a cash dividend for the fourth ...
AUSTIN, Texas, Nov. 5, 2018 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced financial results for the third quarter of 2018. Financial and operating highlights ...
